Materiality
90
earnings
Source
External coverage
Decided
2026-07-14
Agenus reported first-quarter 2026 results and highlighted BOT+BAL execution across global access and Phase 3 development.
View event details3 more curated
AGEN
AgenusDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
Curated Events
4
Active
Recent Headlines
0
New
Recent news sentiment
-0.3
30-day score
Company
-
30-day
Macro
-
30-day
Pulse
-
30-day
Curated events
Sentiment decomposition
-0.3
30-day score
Company-55%
Macro-30%
Pulse-15%
The 30-day sentiment score is a decayed blend of Company, Macro, and Pulse components.
Recent headlines
No supplemental ticker headlines stored yet
We are still collecting relevant articles for AGEN. Curated events highlight the most material developments impacting this ticker right now.
As of 2026-07-14 • Updated scheduledSource: News desk